Validation of in vivo dose using EPID combined with fan-beam CT guidance in post-breast-conserving radiotherapy for early-stage breast cancer

wanli zhu, Jia Fang, Chunyan Dai, Can Liao, Fei Zhao, Yu Wang, Zijie Mo, Yi Zhang, Meiqin Chen, Hongzhi Zhang, Shubo DingResearch Square 2024 · DOI

This study, recently published by researchers at the Affiliated Jinhua Hospital and United Imaging Healthcare, investigates how real-time imaging and dose verification can improve the accuracy of radiotherapy for breast cancer patients. By combining Electronic Portal Imaging Devices (EPID) with diagnostic-grade fan-beam CT (FBCT), the team quantified exactly how much breathing and daily positioning shifts affect the radiation dose actually received by the patient versus what was planned.

TL;DR

Researchers used EPID-based in vivo dosimetry and same-day fan-beam CT to prove that while image guidance significantly improves treatment accuracy, internal motion (like breathing) remains a major source of dosing errors. The study highlights that intra-fractional movement has a more substantial impact on underdosing the target area than session-to-session setup variations.

What Problem Does This Paper Address?

Radiotherapy for breast cancer is a balancing act: clinicians must deliver a high dose to the breast tissue while sparing the heart and lungs. The "gold standard" plan is created from a single CT scan taken days before treatment starts. However, the human body is dynamic.

Between sessions (inter-fractional variance), a patient’s weight might change or their posture might shift. During the treatment itself (intra-fractional variance), the patient breathes, causing the breast and diaphragm to move. These movements can lead to "cold spots" in the tumor area or "hot spots" in healthy organs. This paper addresses the need for real-time validation—confirming that the dose coming out of the machine actually matches the dose absorbed by the patient’s anatomy as it exists at that moment.

Methods

The study followed 26 patients using the uRT-linac 506c, a unique linear accelerator that features a diagnostic-grade 24-row fan-beam CT (FBCT) on the same platform.

  1. In Vivo Dosimetry: They used the EPID—a sensor normally used for imaging—to capture the radiation beam after it passed through the patient.
  2. 2D/3D Reconstruction: Using Monte Carlo algorithms, they converted these EPID signals into 2D "transit images" and 3D dose distributions.
  3. Comparative Analysis: They compared three scenarios:
  4. N-IGRT: No image guidance.
  5. IGRT: Standard image-guided radiotherapy.
  6. FBCT Group: Using the same-day CT scan as the reference for dose calculation.
  7. Gamma Analysis: They used "gamma pass rates" (3mm/3% and 3mm/5% thresholds) to quantify the agreement between the planned and delivered doses.

Datasets

The researchers utilized a clinical dataset from 26 early-stage breast cancer patients (16 left-sided, 10 right-sided) treated between May 2022 and March 2023. This resulted in:

  • 643 total in vivo dose validations.
  • 129 IGRT fractions specifically analyzed for anatomical deformation and organ-at-risk (OAR) volume changes.

Key Insights and Ideas

  • IGRT is Necessary but Not Sufficient: While Image-Guided Radiotherapy (IGRT) significantly boosted the accuracy (gamma pass rates) compared to non-guided sessions, it couldn't completely eliminate dosing errors caused by the displacement of the breast and diaphragm.
  • The "Breathing" Penalty: The study found that intra-fractional motion (breathing during the beam-on time) caused a more significant underdose to the target area (PTV D95) than the daily setup errors. Specifically, the mean underdose due to internal motion was roughly double that caused by setup variations.
  • Heart vs. Lung Variability: The heart showed much higher volume variability across sessions than the lungs. This is likely due to the combination of respiratory motion and the heart’s own rhythmic pulsation, making it a particularly difficult organ to shield consistently.
  • Threshold Realism: The authors suggest that the common 3mm/3% gamma threshold might be too stringent for breast radiotherapy under free-breathing conditions, noting that a 3mm/5% threshold might be more clinically representative of successful delivery in these cases.

Key Results

  • Accuracy Boost: The IGRT group achieved a 2D gamma pass rate (3mm/3%) of ~92.99%, significantly higher than the ~88.51% seen in the non-IGRT group.
  • FBCT Superiority: Using same-day FBCT as the reference further improved the 3D gamma pass rates to over 98% (at the 3mm/5% level).
  • Dosimetric Impact: For left-sided patients, inter-fractional differences caused an average heart dose (Dmean) deviation of 8.21%.
  • Target Underdose: Internal motion led to a mean underdose of 3.39% for left breast targets and 3.66% for right breast targets.

Limitations and Future Work

The primary limitation is the small sample size of 26 patients, which limits the generalizability of the statistical correlations. Additionally, while the study quantified the deformation of the target area, it did not deeply explore the specific mathematical correlation between the "Deformation Index" and the resulting dose drop-off.

The authors conclude that to truly solve the issues identified, clinics should move toward adaptive radiotherapy (re-planning the treatment daily based on that day's CT) and respiratory motion management, such as Deep Inspiration Breath Hold (DIBH), to "freeze" the anatomy in a repeatable position.

Summary updated

Abstract

<title>Abstract</title> <bold>Objective</bold> To explore the application of in vivo dose validation during post-breast-conserving radiotherapy for early breast cancer and the impact of image guidance on validation outcomes, as well as to examine the influence of inter- and intra-fractional variances on dose distribution. <bold>Methods</bold> Twenty-six patients undergoing post-breast-conserving radiotherapy for early-stage breast cancer were selected for in-treatment in vivo dose validation. The retrospective analysis examined the results of in vivo dose validation across different image-guided modalities. Utilizing the image-guided images, the target area and organs at risk were redefined to quantitatively assess the effect of inter- and intra-fractional differences on the dose distribution. <bold>Results</bold> The 3mm3%/3mm5% 2Dγ-pass (gamma pass) rates in the image-guided radiotherapy(IGRT) group were significantly higher than those in the non-IGRT(N-IGRT) group for both left and right breast cancer (p&lt;0.05). Additionally, the 3mm 5% 2Dγ-pass rate of fan beam CT(FBCT) group was higher than that of IGRT group, and was statistically significant (p&lt;0.05). The inter-fractional differences in the left breast cancer patients mainly affected the target area parameters primary gross tumor volume(PGTV) D95, PGTV D2, planning target volume(PTV) D95, PTV D90, heart Dmean and V5, lung V5, and were statistically significant (p&lt;0.05). The effects of intra-fractional differences on dose distribution were statistically significant except for cardiac Dmean (p&lt;0.05). Similarly, inter-fractional differences in right breast cancer patients significantly affected the dose distribution of parameters such as PGTV D95, PGTV D2, PTV D95, PTV D90, Heart Dmean, Lung V5, and were statistically significant (p&lt;0.05), while the effect of intra-fractional differences on dose distribution was statistically significant for all parameters (p&lt;0.05). <bold>Conclusion</bold> Electronic portal imaging device (EPID) in vivo dose validation combined with fan-beam CT image guidance offers an accurate assessment of real-time dose delivery in breast cancer radiotherapy patients. This approach provides a foundation for implementing respiratory motion management and adaptive radiotherapy strategies for breast cancer treatment.
BibTeX
@inproceedings{zhu2024validation,
  author = {wanli zhu and Jia Fang and Chunyan Dai and Can Liao and Fei Zhao and Yu Wang and Zijie Mo and Yi Zhang and Meiqin Chen and Hongzhi Zhang and Shubo Ding},
  title = {{Validation of in vivo dose using EPID combined with fan-beam CT guidance in post-breast-conserving radiotherapy for early-stage breast cancer}},
  booktitle = {Research Square},
  year = {2024},
  doi = {10.21203/rs.3.rs-4341424/v1},
}
Figure